Key result
Chronic beta-adrenergic hyperstimulation with isoproterenol significantly reduced stroke volume by 38.50% and ejection fraction by 35.61%, while paradoxically increasing myocardial contractility.
Why the study?
Does isoproterenol-induced chronic beta-adrenergic hyperstimulation reduce cardiac pump function in female Wistar rats?
Does isoproterenol-induced chronic beta-adrenergic hyperstimulation reduce cardiac pump function in female Wistar rats?
Effect estimate: reduced by 38.50%
Absolute Event Rate: 64.94% vs 105.59%
p-value: p=<0.01
Chronic beta-adrenergic hyperstimulation in rats leads to impaired diastolic and pump function despite a compensatory increase in myocardial contractility.
May dissociate contractility from pump function in adrenergic overload; leaves open translation to human HF models.
The complex of structural and functional changes of myocardium was investigated in experiments with rats with chronic beta-adrenergic activation for 1 month. We observed substantial attenuation of myocardial pump function, particularly reduction of stroke volume by 38.50% (P < 0.01), cardiac output by 42.38% (P < 0.01), and ejection fraction by 35.61% (P < 0.01). Furthermore, 2-fold increase of end-diastolic left ventricular pressure (P < 0.01) and rise of active relaxation constant Tau by 12.91% (P < 0.05) were observed. This indicates on an impaired diastolic function of the heart that is associated with accumulation of connective tissue elements in myocardium and increase of its end-diastolic stiffness that finally leads to cardiac pump function disturbances. Surprisingly, myocardial contractility was considerably augmented not only after the treatment with beta-adrenergic agonist but also on the 26th day after drug cessation. This phenomenon is associated with elevation of dP/dt(max) by 49.9% (P < 0.01), 2.5-fold increase of end-systolic elastance (P < 0.01) as well as maximal myocardial elastance by 42.53% (P < 0.05). It can be explained by compensatory influence of increased contractility that nevertheless failed to maintain adequate cardiac pump function and furthermore it may result in depletion of cardiac energy resource.
No takes yet. Share an insight, caveat, or question.
Kuz'menko et al. (2011) studied Beta-adrenergic hyperstimulation-induced cardiac remodeling (n=17). Isoproterenol vs. Saline was evaluated on Stroke volume (reduced by 38.50%, p=<0.01). Chronic beta-adrenergic hyperstimulation with isoproterenol significantly reduced stroke volume by 38.50% and ejection fraction by 35.61%, while paradoxically increasing myocardial contractility.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: